4h
Hosted on MSNBridgeBio Oncology to Go Public in SPAC Deal Bringing $450 Million-Plus for Trio of Cancer DrugsClinical-stage BridgeBio Oncology Therapeutics, whose financial backers include Cormorant Asset Management, is going public ...
BridgeBio Oncology Therapeutics, which was spun out of BridgeBio Pharma (NASDAQ:BBIO) last year, has agreed to merge with ...
The merger involves Evolution Metals acquiring the equity interests of Critical Mineral Recovery Inc., which was created to ...
The deal comes amid an uptick in so-called SPAC deals, which had fallen out of favor due to poor returns and increased ...
The SPAC market is finally making a comeback. As we enter a period of the long-awaited SPAC revival, some liability dangers ...
Seyond, a global leader in high-fidelity LiDAR solutions, has announced its upcoming listing on the Hong Kong Stock Exchange (HKEX) through a de-SPAC (special purpose acquisition company) transaction ...
In a move straight out of 2021, BridgeBio Oncology is taking the SPAC route to the public markets in a deal with Helix ...
By far the world's largest concert promoter and event operator, Live Nation announced the decision on its Lawn Pass Facebook ...
The Saratoga Performing Arts Center (SPAC) has announced the appointment of Jana Gordon as its new Senior Vice President of ...
Saratoga Performing Arts Center (SPAC) announced the return of The Philadelphia Orchestra to its summer home in Saratoga ...
Concertgoers who planned to buy a summer lawn pass to see a range of acts at Saratoga Performing Arts Center (SPAC) this year ...
BridgeBio Oncology Therapeutics, a company working to advance the field of therapies addressing a validated but elusive group of cancer targets, has reached a deal to go public in a SPAC merger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results